Clinical Trial Update: Efficacy and Safety of VDPHL01 in Males With AGA [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update for VDPHL01 in men with androgenetic alopecia (AGA). The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• VDPHL01

Snippet

Sponsor: Veradermics, Inc. | Conditions: Androgenetic Alopecia, AGA | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING